Market for analytical and life science instruments projected to grow by 4.5%

LOS ANGELES, Feb. 9, 2017 /PRNewswire/ -- Strategic Directions International (SDi), a division of BioInformatics LLC, today announced the release of the 2017 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry. The 750+ page report details the size, growth and depicts market share for 82 separate categories of laboratory instruments and consumables. In addition, projections are made on the industry's prospects out to 2020 and include technology overviews, and detail market segment and regional developments.

"The $50 billion laboratory market for analytical and life science instruments will likely see an overall growth approaching 4.5% in 2017," said Mike Tice, Vice President of Consulting at SDi. "It's difficult to predict the impact the new administration in the U.S. and Brexit and upcoming elections in Europe will have on the market, but we believe there are pockets of opportunities for growth especially in life sciences and in the applied markets of developing economies."

The 2017 SDi Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for measuring the size and growth of the analytical and life science instrumentation industry. Click here for a complimentary download of the Executive Summary.

The report covers 82 individual instrumentation and related technologies. Each technology is segmented according to several primary classifications typically related to underlying techniques.  The 10 sections include chromatography, life science instrumentation, mass spectrometry, molecular spectroscopy, atomic spectroscopy, surface science, materials characterization, lab automation, general analytical techniques, and lab equipment.

For each instrument and category, the report quantifies the regional distribution of demand; the size of the market segmented according to initial systems, aftermarket, and service; unit shipments/installations; growth rates; and demand by industry and lab function.  Each section also explores the current state of the competitive playing field, including a list of the top vendors' market shares, a vendor participation matrix, recent developments, and concludes with a short discussion that suggests where the market might be headed over the next five years from the related standpoints of technology, competition, and growth.

ABOUT IBO and BIOINFORMATICS LLC

Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics LLC in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. By leveraging our online professional network of tens of thousands of scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers' brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

www.gene2drug.com

For more information contact:

Mike Tice
Vice President of Consulting
Strategic Directions International
A division of BioInformatics LLC
6242 Westchester Parkway, Suite 100
Los Angeles, CA 90045-4820
United States
Phone: 310.641.4982
[email protected] 
www.gene2drug.com

SOURCE BioInformatics LLC

Related Links

http://www.gene2drug.com